Cancer chemoprevention activity of labdane diterpenes from rhizomes of Hedychium coronarium  by Endringer, Denise C. et al.
Rev Bras Farmacogn 24(2014): 408-412
* Corresponding author. 
 E-mail: fernao@netuno.lcc.ufmg.br (F.C. Braga); denise.endringer@ifes.edu.br (D.C. Endringer).
0102-695X/$ - see front matter © 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
http://dx.doi.org/10.1016/j.bjp.2014.08.002
Original article
Cancer chemoprevention activity of labdane diterpenes from 
rhizomes of Hedychium coronarium 
Denise C. Endringera,*, Francisca S.N. Taveirab, Tamara P. Kondratyukc, 
John M. Pezzutoc, Fernão C. Bragaa,* 
aFaculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
bDepartamento de Química, Universidade Federal do Maranhão, São Luís, MA, Brazil
cThe Daniel K. Inouye College of Pharmacy, University of Hawaii at Hilo, Hilo, USA
Introduction
Hedychium coronarium J. Koenig, Zingiberaceae, popularly known 
as butterfly ginger, butterfly lily, cinnamon jasmine, garland flower 
and ginger lily, is a medicinal plant cultivated throughout India, 
Southeast Asian countries, China, Japan and Brazil (Manish, 2013). 
Its rhizomes are widely used in Brazil to treat pain, wounds, 
infections and rheumatism (Pio Corrêa, 1974; Ribeiro et al., 1988). 
Previous studies have demonstrated the anti-inflammatory, 
analgesic and leishmanicidal activities of different extracts from 
the rizhomes of H. coronarium (Braga et al., 1999; Shrotriya et 
al., 2007; Valadeau et al., 2009). Labdane diterpenes, farnesane 
sesquiterpenes and essential oil constituents such as 1,8-cineole, 
E-pinene and D-terpineol have been isolated from the rhizomes 
of this species and anti-inflammatory properties have been 
described (Morikawa et al., 2002; Taveira et al., 2005; Joy et al., 
2007; Chimnoi et al., 2008; Manish, 2013). 
A broad spectrum of biological activities has been described 
for labdane diterpenes, including antibacterial, antiviral, anti-
inflammatory and anti-tumor activities (Ghosh and Karin, 2002; 
Pezzuto et al., 2005; Maiti et al., 2007; Girón et al., 2008; Hegazy 
et al., 2008; Kunnumakkara et al., 2008; Suresh et al., 2010; Zhan 
et al., 2012). Remarkable inhibitory activity of nitric oxide (NO) 
production in LPS-activated mouse peritoneal macrophages 
has been reported for coronarin D and hedychilactone A, 
labdane diterpenes isolated from the rizhomes of H. coronarium 
(Matsuda et al., 2002; Kiem et al., 2012). 
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A B S T R A C T
Hedychium coronarium J. Koenig, Zingiberaceae, is a medicinal plant popularly used to treat 
inflammatory conditions in different countries. Three labdane diterpenes [isocoronarin D 
(1), methoxycoronarin D (2), ethoxycoronarin D (3)] and benzoyl eugenol (4) were isolated 
from rhizomes and their chemopreventive potential was evaluated using in vitro assays, 
namely the inhibition of NF-NB, COX-1 and -2, the induction of antioxidant response 
element (ARE), and the inhibition of cell proliferation. Diterpene 1 activated ARE (EC50 57.6 
± 2.4 μM), while 2, 3 and 4 significantly inhibited NF-NB (IC50 of 7.3 ± 0.3, 3.2 ± 0.3 and 32.5 ± 
4.9 μM, respectively). In addition, 2 and 3 selectively inhibited COX-1 (IC50 values of 0.9 ± 0.0 
and 3.8 ± 0.0 μM, respectively). These data support the potential chemopreventive activity 
of constituents from H. coronarium rhizomes.
© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
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One of the most important steps in the inflammatory 
response is the activation of the nuclear transcription factor-NB 
(NF-NB) (Ghosh and Karin, 2002; Kunnumakkara et al., 2008). 
NF-NB activation is involved in inflammation, cell proliferation 
and oncogenic processes (Skehan et al., 1990; Matsuda et al., 
2002; Pezzuto et al., 2005; Maiti et al., 2007; Kang et al., 2009; 
Kiem et al., 2012). Thus, agents that suppress NF-NB activation 
can abrogate carcinogenesis. This finding has encouraged 
the search for specific inhibitors of NF-NB activation from 
natural sources, which might lead to new candidates for 
cancer chemoprevention (Skehan et al., 1990; Pezzuto et al., 
2005). In addition, COX-2 is induced during the inflammatory 
response and has been implicated in the etiology of cancer 
(Ghosh and Karin, 2002; Maiti et al., 2007; Kunnumakkara et 
al., 2008). Coronarin D has been shown to inhibit the NF-NB 
activation pathway induced by different carcinogens and pro-
inflammatory molecules, and also to impair the expression of 
constitutive NF-NB (Girón et al., 2008; Kunnumakkara et al., 
2008). It also inhibits NF-NB by down regulating IKK activation 
(Girón et al., 2008; Kunnumakkara et al., 2008).
As part of our continuing search for bioactive molecules 
from medicinal plants, herein we report the potential cancer 
chemopreventive activity of labdane diterpenes isolated from 
rhizomes of H. coronarium. Chemopreventive activity was 
assessed by examining in vitro inhibition of NF-NB, COX-1 and 
-2, ARE induction, and cell proliferation inhibition.
Materials and methods
Plant material
The rhizomes of Hedychium coronarium J. Koenig, Zingiberaceae, 
were collected in June 2002, at UFMG campus, in Belo Horizonte, 
Minas Gerais state, Brazil. The species was identified by Dr. J. 
A. Lombardi, from the Departamento de Botânica, Instituto 
de Ciências Biológicas, UFMG, Belo Horizonte, Brazil, where a 
voucher specimen was deposited (BHCB 68447).
Reagents and apparatus 
All chemicals, unless specified otherwise, were purchased from 
Sigma-Aldrich Co. (St. Louis, MO). 
Cell lines 
Cell culture media and supplements were obtained from 
Gibco (Life Technologies, Grand Island, NY). Wild-type HepG2 
and HepG2 transfected with ARE-luciferase plasmid, human 
hepatoma cells, were supplied by Dr. Hong-Jie Zhang (University 
of Illinois at Chicago, Chicago, IL); 293/NF-NB, human embryonic 
kidney  cells, transfected with NF-NB-luciferase plasmid and 
Hygromycin (RC0014) were purchased from Panomics (Fremont, 
CA); LU1, human lung carcinoma cells were supplied by the 
Department of Surgical Oncology, University of Illinois at 
Chicago, Chicago, IL; MCF-7, human breast carcinoma (ATCC 
HTB-22) and hormone-dependent human prostate carcinoma 
LNCaP (ATCC-CRL-1740) were purchased from American Type 
Culture Collection (Rockville, MD). All media were supplemented 
with 10% fetal bovine serum (FBS) (HyClone*Thermo Scientific, 
VWR, Atlanta, GA) containing 100 U/ml penicillin and 0.1 mg/
ml streptomycin. Cells were incubated at 37°C with 5% CO2. All 
cells were kept under twenty passages and used in experiments 
during the linear phase of growth. COX-1 enzyme was purchased 
from Animal Technologies Tyler (Texas). For the assays, the 
compounds were dissolved in dimethyl sulfoxide (DMSO) and 
diluted to their final concentrations. An equivalent volume of 
DMSO was added to control wells and showed no measurable 
effect on the assayed culture cells or enzymes. 
Isolation and identification of constituents of H. coronarium 
After drying at 40°C, for 72 h, the rhizomes of H. coronarium 
were powdered (706.3 g) and percolated with 96% EtOH at 
room temperature. The solvent was removed under reduced 
pressure yielding 81.9 g of a dark residue that was successively 
extracted by partition with n-hexane, dichlorometane 
and methanol yielding three main fractions n-hexane (6.5 
g), dichloromethane (26.0g) and methanol (15.0 g). The 
dichloromethane fraction was re-chromatographed on a 
silica gel column (70-230 mesh, Merck), eluting with n-hexane-
ethyl acetate (95:5-1:1) gradient. The sub-fraction eluted with 
n-hexane-ethyl acetate (9:1) afforded benzoyleugenol (48.8 
mg, 4). The sub-fraction eluted with n-hexane-ethyl acetate 
(85:15) was re-chromatographed on a silica gel column eluting 
with dichloromethane-ethyl acetate (100:0-0:100) gradient. 
The sub-fraction eluted with 100% of dichloromethane 
yielded isocoronarin D (1, 311.2 mg) and the one eluted with 
DCM:EtOAc (98:2) yielded ethoxycoronarin D (epimers, 3a/3b, 
44.0 mg). The methanol fraction was re-chromatographed on a 
silica gel column, eluting with dichloromethane-ethyl acetate 
(100:0-0:100) gradient. The sub-fraction eluted with 100% of 
dichloromethane yield methoxycoronarin D (epimers, 2a/2b, 
5.8 mg). Isocoronarin D was isolated as a pure compound. 
Structure identification was accomplished by spectroscopic 
methods (Taveira et al., 2005).
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Luciferase assays
Luciferase assays were conducted as previously described 
(Pezzuto et al., 2005). In brief, transfected cells were incubated 
at an initial density of 1.5 × 105 cells per well for 48 h in 96-well 
plates. After a 6 h incubation with 12-O-tetradecanoylphorbol 
13-acetate (TPA) (100 nM) and test compounds, cells were 
analyzed for luciferase activity. Cells were washed with PBS 
and lysed using 50 μl 1X Reporter Lysis Buffer for 10 min, 
and the luciferase determination was performed according 
to the manufacturer’s protocol (Promega, Madison, WI). 
Data for ARE induction (EC50 values) were expressed as the 
concentration of compound that provoked activation halfway 
between baseline (DMSO control) and maximum response 
at a concentration of 20 μg/ml. NF-kB constructs data were 
expressed as IC50 values (the concentration required to inhibit 
TPA-activated NF-kB activity by 50%). For ARE induction, 
sulforaphane (EC50 4-6 μM) was used as standard inducer. 
Resveratrol was used as a standard TPA-activated NF-kB 
activity inhibitor (IC50 25 mM). IC50 values were generated 
from the results of four serial dilutions of the active samples 
tested in triplicate (Tablecurve 2D, AISN Software, USA, 1996). 
No signs of overt cellular toxicity were observed under the 
employed experimental conditions.
Assay for inhibition of COX-1 and -2 activities 
The effect of test compounds on COX activity was determined 
by measuring PGE2 production as described previously (Kang 
et al., 2009). 
Cell proliferation assay
Cell density determinations were performed as described 
by Skehan et al. (1990). This assay is based on the selective 
binding of sulforhodamine B with cellular proteins (Ahmad 
et al., 2006). The human cancer cell panel was comprised of 
LU-1, LNCaP, HepG2, and MCF-7 cells. The cells were seeded (1 
× 104 cells/well) in 96-well plates; test samples were added at 
various concentrations at day 1 and cell growth was estimated 
at day 4. After the incubation period, cell monolayers were 
fixed with 10% (w/v) trichloroacetic acid and stained for 30 min. 
Excess dye was removed by repeated washing with 1% acetic 
acid. Protein-bound dye was dissolved in 10 mM Tris base 
Compounds
EC50 (μM) IC50 (μM)
ARE NF-NB COX-1 COX-2 LNCaP HepG2
Isocoronarin D (1) 51.2 ± 5.5 > 62.9 >31.5 > 31.5 64.2 ± 14.2 54.7 ± 0.3
Methoxycoronarin D (2) > 60.2 7.2 ± 0.3 0.9 ± 0.0 > 30.1 > 60.2 79.2 ± 25.6
Ethoxycoronarin D (3) > 57.8 3.2 ± 0.3 3.8 ± 0.1 > 28.9 42.2 ± 11.6 > 57.8
Benzoyl-eugenol (4) > 74.6 32.5 ± 4.9 > 74.6 > 37.3 > 74.6 > 74.6
ARE, induction of antioxidant response element; NF-NB, TPA-induced NF-NB inhibition; COX-1 and -2, inhibition of cyclooxgenase -1 and -2;  
anti-proliferative effects against LNCaP and HepG2 cell lines.
Table 1
Cancer chemopreventive activity of compounds isolated from Hedychium coronarium rhizomes. 
solution and measurements were performed at 510 nm using a 
microplate reader. For each cell line, four concentrations were 
tested in triplicate. 
Statistical analyses
Results are presented as means ± standard error. Statistical 
comparisons were performed using the Student’s t-test, and 
the level of p < 0.05 was considered as significantly different. 
Results and discussion
The potential cancer chemopreventive activity elicited by 
compounds isolated from the ethanol extract of Hedychium 
coronarium J. Koenig, Zingiberaceae, rhizomes (EHC) was assayed 
using a battery of in vitro tests (inhibition of NF-NB, COX-1 and 
-2, ARE induction, and cell proliferation). Compounds showing 
at least 50% inhibition at a concentration of 10 μg/ml (COX-1 
and -2) or 20 μg/ml (NF-NB, ARE and cell proliferation) were 
tested in triplicate and dose-response curves were used to 
determine IC50 values. Inhibition of NF-NB and induction of 
ARE were carried out using a luciferase reporter gene assay 
(Kang et al., 2009). The results are shown in Table 1. 
Fractionation of EHC by silica gel column chromatography 
followed by semi-preparative HPLC afforded compounds 1-4 
(Taveira et al., 2005), whose chemical structures are depicted 
in Fig. 1. Compounds 2 and 3 were obtained as epimeric 
mixtures at C-15 (Taveira et al., 2005). The labdane diterpenes 
1-3 differ only in the substitution pattern of the lactone ring, 
i.e., 1 bears a hydroxyl group at C-14, while 2 and 3 present 
methoxy and ethoxy groups at C-15. The different biological 
responses elicited by these compounds suggest the influence 
of the substituents. 
Therefore, ARE induction promoted by compound 1 
(EC50 57.6 ± 2.4 μM) decreased significantly by introducing 
a substituent at C-15 and by removing the hydroxyl group 
at C-14, as observed with 2 and 3 (EC50 > 60.2 and > 57.8 μM, 
respectively). On the other hand, these features dramatically 
increased the NF-NB inhibitory potency of 2 and 3 (IC50 7.3 ± 
0.3 and 3.2 ± 0.3 μM, respectively), in comparison to 1, regarded 
as inactive (IC50 > 62.9 μM). The epimeric mixture of coronarin 
D has been previously reported to inhibit the NF-NB pathway 
(Kunnumakkara et al., 2008). Our data show a two-fold increase 
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in the inhibition against this target when the methoxy group 
at C-15 is replaced by an ethoxy moiety. These changes 
possibly interfere with the Michael acceptor character of the D, 
E-unsaturated carbonyl groups of these derivatives. The active 
Michael acceptor groups have been shown to react with critical 
cysteines of target proteins, and could interact with the cysteine 
residue 179 (C179) of IKK-E, a INB kinase-E which releases NFNB 
by phosphorylation of INB (Ahmad et al., 2006; Hee-Juhn et 
al., 2007; Girón et al., 2008; Kunnumakkara et al., 2008). This 
assumption is supported by the work of Girón et al. (2008), 
which demonstrated the potential anti-inflammatory activity 
of two compounds from a library of hispanolone labdane-type 
diterpenes. According to these authors, the effects are mediated 
by the inhibition of IKK activity, which results in stabilization of 
the NF-NB/INB complex and consequently impairs the nuclear 
translocation of NF-NB (Girón et al., 2008; Kunnumakkara 
et al., 2008). The active compounds described by Girón et al. 
(2008) bear one or two Michael acceptors as functional groups, 
whereas this feature is absent in the inactive structurally-
related diterpenes. Recently, other labdane diterpenes isolated 
from H. coronarium, hedycoronen A and hedycoronen B, showed 
moderate inhibitory activity on TNF-D production ( IC50 46.0 ± 
1.3 and 12.7 ± 0.3 μM, respectively), whereas the corresponding 
deoxymethyl derivatives were inactive (Kiem et al., 2012). This 
finding suggests that the inhibitory effect against some nuclear 
factors increases by introducing a methoxy or ethoxy group at 
the C-15/16 positions. 
Regarding COX-1 and -2 inhibition, the presence of a 
methoxy group at C-15 (compound 2; IC50 0.9 ± 0.0 μM) led to 
an increase of potency against COX-1, in a selective manner, in 
comparison to derivative 3 (IC50 3.8 ± 0.1 μM), which bears an 
ethoxy group. These compounds did not inhibit COX-2 under 
these assay conditions.
In addition to labdane diterpenes, fractionation of H. 
coronarium rhizomes afforded benzoyl eugenol (4), a derivative 
of eugenol. This compound showed weak activity (IC50 32.5 
± 4.9 μM) in the NF-NB inhibition assay and was considered 
inactive in the ARE induction assay as well as in the COX-1 
and -2 inhibition assays. Resveratrol is chemically related to 4, 
since both compounds have a phenylpropanoid group, but with 
different location of the second aryl ring. Recently, two libraries 
of resveratrol derivatives were designed to evaluate structure 
features that could improve selective inhibition of NF-NB, 
COX-1 or COX-2 (Nakatani et al., 1994; Pezzuto et al., 2005). 
Among the COX-1 and -2 inhibitors, the absence of electronic-
donating atoms between the two aryl rings seems to be an 
important structure feature for activity (Skehan et al., 1990; 
Handler et al., 2007). This requisite is violated by compound 
4, which possess an ester moiety that may account for its 
inactivity on the COX assay. Additionally, derivatives with a 
withdrawing substituent were either inactive or weakly active 
in the NF-NB inhibition assay (Pezzuto et al., 2005). The ester 
carbonyl group present in compound 4 fulfills this feature, and 
this is probably related with its low NF-NB inhibitory activity. 
To further assess the potential of diterpenes 1-3 as cancer 
chemopreventive agents, their cytotoxicity was determined 
against four cell lines (HepG2, LU-1, LNCaP, and MCF-7), at 
concentrations up to 20 μg/ml. Proliferation suppression 
with LU-1 and MCF-7 cells was not significant, whereas weak 
antiproliferative effects against HepG2 (1 and 2) and LNCaP 
(1 and 3) was observed (Table 1). The HepG2 antiproliferative 
activity exhibited by compound 1 could be related to ARE 
induction activity, since the ARE-luciferase plasmids 
transfected cells are constructed from the HepG2 cell line. The 
low cytoxicity of compound 2 in cancer cells MCF-7, A549 and 
SK-N-SH (Suresh et al., 2010),  and Hela and HUMEC has been 
also reported (Zhan et al., 2012). 
Altogether, these results indicate that the cancer 
chemoprevention effect of the labdane diterpenes from H. 
coronarium most probably involve the inhibition of NF-NB, which 
may also account for the alleged anti-inflammatory activity of 
the plant. An increase in the liposolubility of these labdanes 
increased NF-NB inhibition and decreased cytotoxicity. These 
data suggest the potential cancer chemopreventive activity of 
methoxy and ethoxy labdanes from H. coronarium.
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